EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Bax/Bcl-2 Ratio as the Golden Marker of Apoptosis: Molecular Mechanisms and Regulatory Pathways

Ghea Farmaning Thias Putri, Zahara Nurfatihah Z

International Journal of Cell and Biomedical Science · 12.10.2025 · 4 (10) · 309-317

DOI: 10.59278/cbs.v4i10.65 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cell and Biomedical Science, online erschienen am 12.10.2025. Verfasst von Ghea Farmaning Thias Putri und 1 weiteren Autor:innen. Die Arbeit wurde bisher 31-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Apoptosis is an essential biological mechanism responsible for maintaining tissue homeostasis by removing unnecessary or damaged cells. Among the key molecular regulators, the interplay between the pro-apoptotic protein Bax and the anti-apoptotic protein Bcl-2 determines cellular fate. The Bax/Bcl-2 ratio has been recognized as the “golden marker” of apoptosis, representing the fine equilibrium between survival and death signaling pathways within cells. This review aims to provide an updated overview of recent advances in understanding the molecular mechanisms and regulatory networks that control the Bax/Bcl-2 ratio and its significance as a diagnostic and therapeutic biomarker. Relevant studies were systematically identified from PubMed, Scopus, ScienceDirect, and Google Scholar, focusing on publications from 2020 to 2025. Current evidence suggests that the Bax/Bcl-2 ratio is influenced by transcriptional regulation involving p53, NF-κB, and Akt/PI3K pathways, as well as by post-translational modifications such as phosphorylation and ubiquitination that govern mitochondrial membrane permeabilization. Clinically, alterations in this ratio correlate with disease progression, therapeutic response, and prognosis in cancer, neurodegenerative, and renal disorders. Targeting this ratio through modulation of upstream regulators or BH3 mimetics offers promising therapeutic potential. In conclusion, a deeper understanding of the Bax/Bcl-2 ratio provides crucial perspectives for advancing diagnostic innovation and developing targeted therapies for apoptosis-related diseases.

Zitieren

APA

Putri, G. F. T., & Z, Z. N. (2025). Bax/Bcl-2 Ratio as the Golden Marker of Apoptosis: Molecular Mechanisms and Regulatory Pathways. International Journal of Cell and Biomedical Science, 4(10), 309-317. https://doi.org/10.59278/cbs.v4i10.65

Vancouver

Putri GFT, Z ZN. Bax/Bcl-2 Ratio as the Golden Marker of Apoptosis: Molecular Mechanisms and Regulatory Pathways. International Journal of Cell and Biomedical Science. 2025;4(10):309-317. doi:10.59278/cbs.v4i10.65

BibTeX
@article{Putri2025,
  author = {Putri, Ghea Farmaning Thias and Z, Zahara Nurfatihah},
  title = {Bax/Bcl-2 Ratio as the Golden Marker of Apoptosis: Molecular Mechanisms and Regulatory Pathways},
  journal = {International Journal of Cell and Biomedical Science},
  year = {2025},
  volume = {4},
  number = {10},
  pages = {309--317},
  doi = {10.59278/cbs.v4i10.65}
}
Kostenlos starten →